Date published: 2026-6-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

S-100A10 Inhibitors

S-100A10 inhibitors constitute a diverse class of chemicals designed to modulate the activity of the S-100A10 protein, which plays a crucial role in various cellular processes. This class of inhibitors can be broadly categorized into two groups: direct and indirect modulators, each shedding light on the intricate regulatory networks governing S-100A10. Direct inhibitors focus on disrupting the interaction between S-100A10 and annexin A2, a critical molecular complex. FL-160, TAS-301, and NSC 95397 are representative members of this category, each possessing distinct chemical structures and mechanisms of action. For instance, FL-160 acts by specifically targeting the binding site between S-100A10 and annexin A2, thereby impeding their functional collaboration. These direct inhibitors serve as valuable molecular tools, allowing researchers to dissect the functional consequences of disrupting the S-100A10-annexin A2 complex with high precision.

On the other hand, indirect inhibitors, including CP-673451, Ro 31-8220, AZD8055, SB 203580, PP2, LY294002, PD 98059, AG 490, and SP600125, offer a broader perspective on the regulatory landscape of S-100A10. These compounds interact with diverse signaling pathways, such as EGFR, PKC, mTOR, p38 MAPK, Src kinases, PI3K, MEK/ERK, JAK2, and JNK. By interfering with these pathways, indirect inhibitors disrupt downstream signaling events associated with S-100A10 activity. This disruption provides researchers with valuable insights into the multifaceted roles of S-100A10 in cellular processes beyond its direct interaction with annexin A2. In conclusion, the dual categorization of S-100A10 inhibitors into direct and indirect modulators not only highlights the diversity within this chemical class but also underscores their significance as precise tools for unraveling the complexities of S-100A10-mediated cellular regulation. These inhibitors, with their distinct modes of action, pave the way for a comprehensive understanding of the intricate signaling networks governed by S-100A10 in various cellular contexts.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

TAS-301

193620-69-8sc-215942
10 mg
$143.00
(0)

TAS-301 is a chemical inhibitor that directly influences S-100A10 by disrupting its interaction with annexin A2. By binding to S-100A10, TAS-301 interferes with the formation of the S-100A10/annexin A2 complex, thereby modulating downstream signaling pathways regulated by this interaction.

NSC 95397

93718-83-3sc-203654
sc-203654A
10 mg
50 mg
$255.00
$847.00
9
(1)

NSC 95397 is a chemical inhibitor that directly targets S-100A10, inhibiting its interaction with annexin A2. By interfering with the S-100A10/annexin A2 complex, NSC 95397 modulates downstream signaling events associated with this interaction.

Ro 31-8220

138489-18-6sc-200619
sc-200619A
1 mg
5 mg
$92.00
$245.00
17
(1)

Ro 31-8220 is a chemical inhibitor that indirectly influences S-100A10 by targeting protein kinase C (PKC). By inhibiting PKC, Ro 31-8220 disrupts downstream signaling cascades that regulate S-100A10 activity. This indirect modulation provides a tool for investigating the interplay between PKC-dependent signaling and S-100A10-mediated cellular processes.

AZD8055

1009298-09-2sc-364424
sc-364424A
10 mg
50 mg
$163.00
$352.00
12
(2)

AZD8055 is a chemical inhibitor that indirectly modulates S-100A10 by targeting the mechanistic target of rapamycin (mTOR) signaling pathway. By inhibiting mTOR, AZD8055 disrupts downstream signaling events that regulate S-100A10 activity. This indirect modulation provides a tool for investigating the interplay between mTOR-dependent signaling and S-100A10-mediated cellular processes. A

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB 203580 is a chemical inhibitor that indirectly influences S-100A10 by targeting p38 mitogen-activated protein kinase (MAPK). By inhibiting p38 MAPK, SB 203580 disrupts downstream signaling cascades that regulate S-100A10 activity. This indirect modulation provides a tool for investigating the interplay between p38 MAPK-dependent signaling and S-100A10-mediated cellular processes.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

PP2 is a chemical inhibitor that indirectly modulates S-100A10 by targeting Src family kinases. By inhibiting Src kinases, PP2 disrupts downstream signaling events that regulate S-100A10 activity. This indirect modulation provides a tool for investigating the interplay between Src kinase-dependent signaling and S-100A10-mediated cellular processes.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a chemical inhibitor that indirectly influences S-100A10 by targeting phosphoinositide 3-kinase (PI3K) signaling. By inhibiting PI3K, LY294002 disrupts downstream signaling events that regulate S-100A10 activity. This indirect modulation provides a tool for investigating the interplay between PI3K-dependent signaling and S-100A10-mediated cellular processes.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 is a chemical inhibitor that indirectly modulates S-100A10 by targeting the mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathway. By inhibiting MEK/ERK, PD 98059 disrupts downstream signaling events that regulate S-100A10 activity.

Tyrphostin B42

133550-30-8sc-3556
5 mg
$26.00
4
(1)

AG 490 (Tyrphostin B42) is a chemical inhibitor that indirectly influences S-100A10 by targeting Janus kinase 2 (JAK2) signaling. By inhibiting JAK2, AG 490 disrupts downstream signaling events that regulate S-100A10 activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a chemical inhibitor that indirectly influences S-100A10 by targeting c-Jun N-terminal kinase (JNK) signaling. By inhibiting JNK, SP600125 disrupts downstream signaling cascades that regulate S-100A10 activity. This indirect modulation provides a tool for investigating the interplay between JNK-dependent signaling and S-100A10-mediated cellular processes.